Kitazato Corporation
JPX: 368A.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Futoshi Inoue
- Employees
- 86
- Headquarters
- Shizuoka, Japan
- IPO year
- 2025
- Market cap
- ¥50.6B
- Website
- https://www.kitazato.co.jp
Loading 368A…
Loading profile data…Frequently asked questions about 368A
What does Kitazato Corporation (368A.T) do?
Kitazato Corporation researches, develops, manufactures, and markets medical devices and related products for fertility treatment. It offers needles, catheters and cannulas, vitrification media and equipment, sperm processing medium/tools, IVF medium products, micro tools, and labware products. The company was formerly known as Kitazato Biopharm...
Where does 368A.T trade?
Kitazato Corporation (368A.T) trades on the Tokyo Stock Exchange.
What sector is 368A.T in?
Kitazato Corporation (368A.T) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Kitazato Corporation?
Futoshi Inoue is the chief executive officer of Kitazato Corporation (368A.T).
Where is Kitazato Corporation headquartered?
Kitazato Corporation is headquartered in Japan.
Does 368A.T pay a dividend?
Yes — Kitazato Corporation (368A.T) paid a trailing twelve-month dividend of JPY 41.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 368A.T go public?
Kitazato Corporation (368A.T) completed its initial public offering in 2025.